SORBI, Claudia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.754
EU - Europa 4.460
AS - Asia 2.621
SA - Sud America 427
AF - Africa 58
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.350
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.643
IT - Italia 1.041
GB - Regno Unito 1.027
CN - Cina 808
SG - Singapore 768
SE - Svezia 642
DE - Germania 595
HK - Hong Kong 412
BR - Brasile 352
FI - Finlandia 260
RU - Federazione Russa 229
VN - Vietnam 154
FR - Francia 126
UA - Ucraina 120
TR - Turchia 101
BE - Belgio 89
KR - Corea 77
CA - Canada 71
BG - Bulgaria 68
IN - India 68
NL - Olanda 57
ID - Indonesia 48
IE - Irlanda 45
JP - Giappone 32
RO - Romania 30
LT - Lituania 29
IR - Iran 28
MX - Messico 27
PL - Polonia 26
AR - Argentina 25
NZ - Nuova Zelanda 23
AT - Austria 19
BD - Bangladesh 19
ZA - Sudafrica 17
ES - Italia 16
IL - Israele 16
TW - Taiwan 14
EC - Ecuador 13
AE - Emirati Arabi Uniti 11
NO - Norvegia 11
EG - Egitto 10
CL - Cile 9
IQ - Iraq 9
CH - Svizzera 8
KE - Kenya 8
PK - Pakistan 8
CO - Colombia 7
VE - Venezuela 7
CZ - Repubblica Ceca 6
KZ - Kazakistan 6
CI - Costa d'Avorio 5
PE - Perù 5
EU - Europa 4
PY - Paraguay 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
AU - Australia 3
AZ - Azerbaigian 3
BY - Bielorussia 3
CR - Costa Rica 3
DZ - Algeria 3
LB - Libano 3
LU - Lussemburgo 3
MY - Malesia 3
NG - Nigeria 3
NP - Nepal 3
PH - Filippine 3
TH - Thailandia 3
UG - Uganda 3
UY - Uruguay 3
AO - Angola 2
BH - Bahrain 2
DK - Danimarca 2
EE - Estonia 2
JO - Giordania 2
MM - Myanmar 2
NI - Nicaragua 2
SN - Senegal 2
SV - El Salvador 2
AF - Afghanistan, Repubblica islamica di 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 14.342
Salva come PNG Salva come JPEG
Città #
Southend 644
Santa Clara 630
Ashburn 530
Fairfield 517
Singapore 459
Hong Kong 395
Chandler 389
Woodbridge 353
Ann Arbor 329
Munich 324
Hefei 282
Nyköping 280
Houston 271
Seattle 256
Chicago 234
Jacksonville 223
New York 213
Wilmington 191
Dearborn 189
Cambridge 187
Helsinki 184
Modena 184
Beijing 172
London 145
Los Angeles 139
Brussels 89
Salt Lake City 83
Milan 74
Sofia 66
Council Bluffs 65
Seoul 65
San Diego 61
Ho Chi Minh City 59
Eugene 53
Princeton 53
Elk Grove Village 48
Izmir 45
Dublin 44
Bologna 42
Moscow 40
Tampa 39
São Paulo 35
Fremont 33
Hanoi 33
Jakarta 33
Buffalo 32
Toronto 30
Tokyo 29
Amsterdam 28
Redwood City 28
The Dalles 26
Bremen 25
Dallas 25
Auckland 23
Frankfurt am Main 23
Shanghai 23
Turku 23
Sochi 22
Boardman 21
Rome 21
Yalova 20
Sterling 19
Augusta 17
Norwalk 17
Reggio Emilia 17
Parma 16
Brooklyn 15
Grafing 15
Jyväskylä 15
Warsaw 15
Guangzhou 14
Mexico City 14
Philadelphia 14
Phoenix 14
San Francisco 14
Denver 13
Kent 13
Lancaster 13
Boston 12
Chennai 12
Des Moines 12
Horia 12
Leawood 12
Montreal 12
Paris 12
Stockholm 12
Zanjan 12
Columbus 11
Falkenstein 11
Jerusalem 11
Orem 11
West Jordan 11
Atlanta 10
Groningen 10
Hillsboro 10
Johannesburg 10
Mumbai 10
Nuremberg 10
Belo Horizonte 9
Tromsø 9
Totale 9.675
Salva come PNG Salva come JPEG
Nome #
1,3-Dioxolane-Based Ligands Incorporating a Lactam or Imide moiety: Structure-Affinity/Activity Relationship at alpha1–Adrenoceptor subtypes and at 5-HT1A Receptors 694
(2,2-difenil-[1,3]-diossolan-4ilmetil)-(3-fenil-propil)-ammina: nuovo agonista parziale del recettore serotoninergico 5-HT1A 600
1,3-Dioxane as a scaffold for potent and selective 5-HT1AR agonist with in-vivo anxiolytic, anti-depressant and anti-nociceptive activity 515
1,3-Dioxolane-Based Ligands as a Novel Class of Alpha1-Adrenoceptor Antagonists 469
1,3-Dioxolane-Based Ligands as Rigid Analogues ofNaftopidil: Structure–Affinity/Activity Relationships at a1and 5-HT1A Receptors 437
Enantiomeric resolution of [(2,2-diphenyl-1,3-dioxolan-4-yl)methyl](2-phenoxyethyl)amine, a potent α1and 5-HT1Areceptor ligand: an in vitro and computational study 408
1,4-Dioxolane-triazaspirodecanone derivatives as nociceptin/orphanin FQ receptor ligands 406
(2,2-Diphenyl-[1,3]oxathiolan-5-ylmethyl)-(3-phenylpropyl)-amine: a Potent and Selective 5-HT1A Receptor Agonist 399
1,3-dioxolane-based ligands in the search for alpha1-adrenergic antagonists. 394
Discovery of a new 5-HT1A receptor agonist, acting ‘in vivo’ in a rat model of anxiety and depression 385
A New and Versatile Synthesis of 1,3-Dioxan-5-yl-pyrimidine and Purine Nucleoside Analogues 331
Discovery Of New Sigma-2 Receptor Agonist Endowed With Antiproliferative Activity 320
Synthesis of 6-O-methotrexylhyaluronan as a drug delivery system 312
A homology modelling-driven study leading to the discovery of the first mouse trace amine-associated receptor 5 (TAAR5) antagonists 312
Synthesis, biological evaluation and molecular modeling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists 307
Synthesis and structure-activity relationships of 1-aralkyl-4- benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent σ ligands 296
Structure-affinity/activity relationships of 1,4-dioxa-spiro[4.5]decane based ligands at α1 and 5-HT1A receptors 290
Structure-Activity Relationship within a new series of σ1 and σ2 receptor ligands: identification of a novel σ2R agonist (BS148) with selective toxicity against metastatic melanoma 285
Diastereoselective Synthesis of (1,3-Dioxan-4-yl)pyrimidine and Purin Nucleoside Analogues 284
Discovery of a new series of 5-HT1A receptor agonists 276
Synthesis and biological evaluation of 1,3-dioxolane-based 5-HT 1A receptor agonists for CNS disorders and neuropathic pain 274
Synthesis, structural characterization and biological evaluation of 4′-C-methyl- and phenyl-dioxolane pyrimidine and purine nucleosides 253
Structure-activity relationship at alpha-adrenergic receptors within a series of imidazoline analogues of cirazoline 246
Investigation of the effect of different linker chemotypes on the inhibition of histone deacetylases (HDACs) 244
Exhaustive CoMFA and CoMSIA analyses around different chemical entities: A ligand-based study exploring the affinity and selectivity profiles of 5-HT1A ligands 238
Synthesis of 5-Methyl-1,3-oxathiolane-based Nucleoside Analogues as Potential Antiviral Agents 229
Transacetalization of Acetals with Butane-1,2,4-triol Using Cobalt(II) Chloride and Chlorotrimethylsilane 229
Synthesis and Structure-Activity Relationships of Triazaspirodecanone Derivatives as Nociceptin/Orphanin FQ Receptor Ligands 229
BS148 Reduces the Aggressiveness of Metastatic Melanoma via Sigma-2 Receptor Targeting 224
Scouting Sigma Receptor Ligands As New Tools For The Treatment Of Neurodegenerative Diseases And Cancer 215
Synthesis, biological evaluation and molecular modelling of 1-oxa-4-thiaspiro- and 1,4-dithiaspiro[4.5]decane derivatives as potent and selective 5-HT1A receptor agonists 214
Structure Activity Relationships at 5-HT1A receptors within a novel series of 4-alkyl-1-arylpiperazine derivatives 209
Synthesis, enantiomeric separation and docking studies of spiropiperidine analogues as ligands of the nociceptin/orphanin FQ receptor 205
Discovery of potent pyrrolo-pyrimidine and purine HDAC inhibitors for the treatment of advanced prostate cancer 202
Effect of the rigidification of propranolol, a mixed β-adrenoceptor and 5-HT1AR antagonist 202
Pyrrolidine Derivatives as New Ligands for 5-HT1A Receptors 200
DAT atypical inhibitors as novel antipsychotic drugs 199
Synthesis, absolute configuration and antimuscarinic activity of the enantiomers of [1-(2,2-diphenyl-[1,3]dioxolan-4-yl)-ethyl]dimethyl-amine 194
Identification of a Potent and Selective 5-HT1AReceptor Agonist with In Vitro and In Vivo Antinociceptive Activity 194
Novel Dithiolane-Based Ligands Combining Sigma and NMDA Receptor Interactions as Potential Neuroprotective Agents 187
Synthesis, structural characterization and pharmacological evaluation of spiroxatrine analogs as potential nociceptin/orphanin FQ receptor ligands 174
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding group 172
Derivati 1,3-Diossanici come Antagonisti Muscarinici 162
Synthesis and pharmacological evaluation of Spiroxatrine derivatives as potential ligands for NOP receptor 152
Relazioni struttura-attività in una nuova serie di ligandi alpha1-adrenergici e 5-HT1A serotoninergici a struttura 2,2-difenil-[1,3]diossolanica 150
Synthesis and structural characterization of spiroxatrine derivatives as potential non-peptide ligands for NOP receptor 146
Spiroxatrine derivatives towards 5-HT1A receptor selectivity 146
Constrained 1,4-dialkylpiperazines as monoamine transporters inhibitors for cocaine-related abuse 146
IDENTIFICATION OF POTENT 1,3-DIOXOLANE-BASED 5-HT1A RECEPTOR AGONISTS FOR THE TREATMENTS OF CNS DISORDERS AND PAIN 141
Nuova Serie di Ligandi Sigma a Struttura Piperazinica e Piperidinica 140
Synthesis and biological evaluation of Hsp90/HDAC6 dual inhibitors bearing a 2-amino-pyrrolopyrimidine and purine scaffold as potential anticancer drugs to treat prostate cancer 134
Novel S1R agonists counteracting NMDA excitotoxicity and oxidative stress: A step forward in the discovery of neuroprotective agents 134
Effect of the replacement of the o-methoxyphenyl moiety with nitrogen-containing aromatic rings within N-phenyl-piperazine and phenoxy-ethylamine-based 1,3-dioxo/oxathio/dithiolanes as α1 and 5-HT1A receptor ligands 133
1,3-Dithiolane as a Privileged Scaffold in Bioactive Derivatives: Chiral Resolution and Assignment of Absolute Configuration 124
Structure-Activity Relationships at alpha1-Adrenoceptor Subtypes within a New Series of 1,3-Dioxolane Derivatives 121
TB62, A POTENT 5-HT1A SEROTONERGIC FULL AGONIST, ENDOWED WITH DUAL ANTINOCICEPTIVE AND ANXIOLITIC/ANTIDEPRESSANT ACTIVITY 96
Insights into the Structural Conformations of the Tau Protein in Different Aggregation Status 91
Farmaci attivi sul sistema nervoso adrenergico 52
Totale 14.521
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.791
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021905 0 0 0 0 0 101 182 145 103 183 129 62
2021/20221.192 64 106 77 90 49 95 38 65 175 86 206 141
2022/20231.406 221 168 114 151 147 163 42 107 163 46 59 25
2023/2024948 20 51 99 103 216 86 58 126 9 38 69 73
2024/20253.334 161 41 72 163 487 443 472 285 323 156 319 412
2025/20262.990 370 223 462 789 1.069 77 0 0 0 0 0 0
Totale 14.521